Potomac, MD, United States of America

Louis William Licamele

This inventor holds 45 USPTO granted patents and 24 published patent applications, plus 8 CIPO patents and 15 EPO patents, primarily in Cancer Treatment. Top assignee: Vanda Pharmaceuticals Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Louis William Licamele. Retrieved from https://idiyas.com/inventor/louis-william-licamele

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 45 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.2

ph-index = 8

Forward Citations = 191(Granted Patents)


Location History:

  • Gaithersburg, MD (US) (2014 - 2016)
  • Potomac, MD (US) (2014 - 2024)

Company Filing History:


Years Active: 2014-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cancer Treatment
Circadian Rhythm Disorders
QT Prolongation
Tradipitant
Multiple Myeloma
Antipsychotic Treatment
SNP Genotype
Genetic Markers
Psychotic Symptoms
Method of Treatment
VEGF-mediated Conditions
CYR61
45 patents (USPTO):Explore Patents

Title: Louis William Licamele: Innovator in Circadian Rhythm Treatment

Introduction

Louis William Licamele, based in Potomac, MD, has established himself as a prolific inventor in the field of circadian rhythm disorders. With an impressive portfolio of 42 patents, he has contributed significantly to the advancement of treatments that address complex sleep-related issues.

Latest Patents

Among his latest inventions, Licamele has developed groundbreaking methods for the treatment of circadian rhythm disorders. These inventions include the use of a melatonin agonist to treat free-running circadian rhythms in patients, particularly those with light perception impairments such as blind individuals. Furthermore, his patents encompass innovative techniques for measuring circadian rhythms, which are paramount for understanding and treating these disorders effectively.

Career Highlights

Licamele is currently affiliated with Vanda Pharmaceuticals Inc., a company known for its focus on innovative treatments for central nervous system disorders. His work at Vanda has allowed him to collaborate with leading professionals in the industry and contribute to cutting-edge research.

Collaborations

Throughout his career, Licamele has collaborated with esteemed colleagues such as Mihael Hristos Polymeropoulos and Marlene Michelle Dressman. These partnerships have enhanced his research and led to fruitful advancements in the field of circadian rhythm treatments.

Conclusion

Louis William Licamele's dedication to innovation in the treatment of circadian rhythm disorders showcases his role as a vital contributor in this specialized area of medicine. Through his numerous patents and collaborations, he continues to influence the development of effective therapies that can significantly improve the quality of life for patients affected by these conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…